Aigen Investment Management, LP Exact Sciences Corp Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$59.06 - $75.72 $536,264 - $687,537
9,080 Added 71.18%
21,836 $1.62 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $841,130 - $1.26 Million
12,756 New
12,756 $870,000
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $757,069 - $1.14 Million
16,043 New
16,043 $1.09 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email